Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06537258 · ClinicalTrials.gov registry record · NA

Heart Rate Variability and Inflammatory Bowel Disease

A NA study of Inflammatory Bowel Diseases, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
3
Study locations

NCT06537258 is a NA study of Inflammatory Bowel Diseases that is actively recruiting participants, run by Emory University. The registered enrollment target is 128 participants, below the 42,259-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06537258, a NA study of Inflammatory Bowel Diseases, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
3
Study locations

Study Summary

The goals of this study are to test the effectiveness of a virtually delivered, group-based coping skills treatment program incorporating heart rate variability biofeedback to target autonomic dysfunction in youth diagnosed with inflammatory bowel disease (IBD). The investigators will enroll participants with IBD in a biofeedback enhanced cognitive behaviorally based coping skills treatment. Participants will be randomized to biofeedback enhanced treatment or wait-list control.

Interventions

  • BEHAVIORAL Biofeedback Enhanced Treatment

Study Locations (3)

Georgia

  • Atlanta Metropolitan Area - Atlanta
  • Children's Healthcare of Atlanta - Atlanta
  • Center for Advanced Pediatrics - Atlanta

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2025-02-06
Est. Completion 2028-10
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT06537258

The ClinicalTrials.gov registry entry for NCT06537258 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 42,259-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammatory Bowel Diseases appearing as the primary indexed condition, and to 1 intervention - of which Biofeedback Enhanced Treatment is the first listed.

NCT06537258 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06537258 about?

NCT06537258 is a clinical study titled "Heart Rate Variability and Inflammatory Bowel Disease". The goals of this study are to test the effectiveness of a virtually delivered, group-based coping skills treatment program incorporating heart rate variability biofeedback to target autonomic dysfunction in youth diagnosed with inflammatory bowel disease (IBD). The investigators will enroll partici...

What is the current status of trial NCT06537258?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-02-06. Estimated completion is 2028-10.

What conditions does trial NCT06537258 study?

This clinical trial studies the following conditions: Inflammatory Bowel Diseases.

What interventions are being tested in trial NCT06537258?

The interventions under investigation include: Biofeedback Enhanced Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT06537258?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06537258 being conducted?

This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammatory Bowel Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.